The Epilepsy Study Consortium - Company Review
The Epilepsy Study Consortium - Company ReviewSummary
The Epilepsy Study Consortium (ESC) is a healthcare organization that develops new therapies in the therapeutic areas of epilepsy to improve patient care. The organization’s services comprise development of trial designs for specific epilepsy syndromes and populations, development of phase II and III trial designs, drug development, development of coordinated processes, and others. It also offers assistance with regulatory submission package, budget development, development of source documents, onsite training, and education services. The organization collaborates with epilepsy centers and clinical trial organization to develop new therapies for the improvement of epilepsy patients’ lives. ESC is headquartered in Woodbury, New Jersey, the US.
This comprehensive company report of The Epilepsy Study Consortium provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.